Paper39488409
Steatotic liver disease.
Israelsen M and 3 others. Lancet, 2024. Cited by 324 papers, by iCite.
Cite this record
ConductScience Library. Steatotic liver disease. Papers, record 39488409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39488409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fatty Liver | Major topic |
| Humans | |
| Non-alcoholic Fatty Liver Disease | |
| Liver Cirrhosis | |
| Disease Progression | |
| Prognosis | |
| Fatty Liver, Alcoholic |
Source PubMed
Cited by221
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 324 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42977875 | Contemporary clinical course of compensated advanced chronic liver disease in a multistate framework. | Hepatol Int | 2026 | https://conductscience.org/library/papers/42977875 | PubMed |
| 42961559 | The role of microbial enzymes in intervention strategies for metabolic diseases targeting the gut microbiota. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42961559 | PubMed |
| 42958515 | A fatty liver index-based sequential strategy for identifying hepatic steatosis in individuals with suspected steatotic liver disease. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42958515 | PubMed |
| 42948769 | Therapeutic targeting of the PRMT6/FOXK1 axis restores lipid homeostasis and ameliorates hepatic steatosis and steatohepatitis in mice. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948769 | PubMed |
| 42928097 | Cardiorespiratory fitness is inversely associated with non-invasive markers of hepatic steatosis and fibrosis: a cross-sectional study of 39,197 UK adults. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42928097 | PubMed |
| 42907789 | B vitamins and metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review of observational studies. | BMC Endocr Disord | 2026 | https://conductscience.org/library/papers/42907789 | PubMed |
| 42879090 | Altered cholangiocyte subsets with neural pathway enrichment in metabolic dysfunction-associated steatotic liver disease. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42879090 | PubMed |
| 42866058 | Omics-based Decoding of Metabolic Dysfunction-associated Fatty Liver Disease: From Pathogenesis to Clinical Translation. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/42866058 | PubMed |
| 42830970 | Vitamin D Deficiency, Inflammatory Biomarkers, and MASLD in Older Adults with Type 2 Diabetes: A Cross-Sectional Study. | Diabetes Metab Syndr Obes | 2026 | https://conductscience.org/library/papers/42830970 | PubMed |
| 42781769 | Diagnostic Accuracy of Serum-Based Fibrosis Scores for Clinically Significant Liver Fibrosis in an East Asian Cohort. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/42781769 | PubMed |
| 42778729 | Splanchnic Vein Thrombosis after Metabolic and Bariatric Surgery: Chilean Position Statement of Hepatology and Bariatric Surgery societies. | Obes Surg | 2026 | https://conductscience.org/library/papers/42778729 | PubMed |
| 42769954 | Impact of long-term fasting on liver and abdominal adipose tissues monitored by quantitative chemical-shift encoded MRI. | Front Nutr | 2026 | https://conductscience.org/library/papers/42769954 | PubMed |
| 42768894 | Discovery of Epidermal Growth Factor-Like 7 as a Potential Non-Invasive Biomarker for Fibrosis and Mortality Risk in MASLD. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42768894 | PubMed |
| 42755179 | Non-Invasive Fibrosis Testing in Adults With Obesity and MASLD: A Systematic Review and Meta-Analysis. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42755179 | PubMed |
| 42738400 | Sex Difference in the Impact of Steatotic Liver Disease on Incident Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738400 | PubMed |
| 42732142 | What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol. | Wellcome Open Res | 2026 | https://conductscience.org/library/papers/42732142 | PubMed |
| 42730872 | Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Drugs | 2026 | https://conductscience.org/library/papers/42730872 | PubMed |
| 42651059 | Analytical Validation and Preliminary Clinical Evaluation of Plasma Carboxylesterase 1 for Ultrasound-Defined Hepatic Steatosis. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42651059 | PubMed |
| 42650820 | Senescence-Related SOCS1, SOCS2, and GADD45G Identify an Immune-Associated Molecular Signature in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650820 | PubMed |
| 42625107 | Non-invasive Assessment and Therapeutic Targeting in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Overcoming the Dissonance Between Drug Development and Precision Medicine. | Drugs | 2026 | https://conductscience.org/library/papers/42625107 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39488409
GET https://conductscience.org/api/papers/v1/39488409/cited_by?page=2